Cargando…

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

Enzyme-linked immunosorbent assay (ELISA) methods and immunohistochemistry (IHC) are techniques that provide information on protein expression in tissue samples. Both methods have been used to investigate the impact of the plasminogen activation (PA) system in cancer. In the present paper we first c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrier, C M, Witte, H H de, Straatman, H, Tienoven, D H van, Geloof, W L van, Rietveld, F J R, Sweep, C G J, Ruiter, D J, Muijen, G N P van
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362713/ https://www.ncbi.nlm.nih.gov/pubmed/10188903 http://dx.doi.org/10.1038/sj.bjc.6690245

Ejemplares similares

High tPA-expression in primary melanoma of the limb correlates with good prognosis
por: Ferrier, C M, et al.
Publicado: (2000)

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours
por: Witte, J H de, et al.
Publicado: (2001)

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer
por: Witte, J H de, et al.
Publicado: (1999)

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients
por: de Witte, J H, et al.
Publicado: (1999)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays
por: de Wit, N J W, et al.
Publicado: (2005)

Comparison of Chemiluminescence Enzyme Immunoassay (Cl-ELISA) with Colorimetric Enzyme Immunoassay (Co-ELISA) for Imidacloprid Detection in Vegetables
por: Zhai, Rongqi, et al.
Publicado: (2023)

High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.
por: de Vries, T. J., et al.
Publicado: (1998)

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood
por: Vries, T J de, et al.
Publicado: (1999)

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
por: Manders, P, et al.
Publicado: (2002)

Prognostic significance of VEGF and components of the plasminogen activator system in endometrial cancer
por: Abbink, Karin, et al.
Publicado: (2020)

BPA Endocrine Disruptor Detection at the Cutting Edge: FPIA and ELISA Immunoassays
por: Raysyan, Anna, et al.
Publicado: (2023)

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.
por: Henzen-Logmans, S. C., et al.
Publicado: (1992)

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
por: Kwaan, H C, et al.
Publicado: (2000)

Relationship between tissue plasminogen activator, plasminogen activator inhibitor and CT image in chronic subdural hematoma.
por: Lim, D. J., et al.
Publicado: (1995)

Prognostic value of urokinase plasminogen activator in primary breast carcinoma: comparison of two immunoassay methods.
por: Bouchet, C., et al.
Publicado: (1998)

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts.
por: Sweep, C. G., et al.
Publicado: (1998)

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.
por: Ganesh, S., et al.
Publicado: (1997)

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
por: Hofmann, U B, et al.
Publicado: (1999)

Independent and functional validation of a multi-tumour-type proliferation signature
por: Starmans, M H W, et al.
Publicado: (2012)

A Rapid, Multiplexed, High-Throughput Flow-Through Membrane Immunoassay: A Convenient Alternative to ELISA
por: Ramachandran, Sujatha, et al.
Publicado: (2013)

Validation of an immunoassay to measure plasminogen-activator inhibitor-1 concentrations in human saliva
por: Zhang, Xi, et al.
Publicado: (2014)

Challenging medical students with an interim assessment: a positive effect on formal examination score in a randomized controlled study
por: Olde Bekkink, Marleen, et al.
Publicado: (2011)

Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs
por: Van Elslande, Jan, et al.
Publicado: (2020)

Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes
por: Aganovic-Musinovic, Izeta, et al.
Publicado: (2012)

Diagnostic performance of commercial IgM and IgG enzyme-linked immunoassays (ELISAs) for diagnosis of Zika virus infection
por: Kikuti, Mariana, et al.
Publicado: (2018)

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
por: Albo, D, et al.
Publicado: (2000)

Evaluation of Real-Time Quaking-Induced Conversion, ELISA, and Immunohistochemistry for Chronic Wasting Disease Diagnosis
por: Holz, Carine L., et al.
Publicado: (2022)

Indirect air CO(2) capture and refinement based on OTEC seawater outgassing
por: Straatman, Paul J.T., et al.
Publicado: (2021)

Increased expression of urokinase type plasminogen activator(u-PA), plasminogen activator inhibitor-1(PAI-1), and collagenases in Caco-2 cells infected by Salmonella typhimurium.
por: Park, C. G., et al.
Publicado: (1997)

Truncated MTA-1: A Pitfall in ELISA-Based Immunoassay of HTLV-1 Infection
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2008)

Recent Advances in Enhancement Strategies for Electrochemical ELISA-Based Immunoassays for Cancer Biomarker Detection
por: Arya, Sunil K., et al.
Publicado: (2018)

Development of a Highly Sensitive and Specific ic-ELISA and Lateral Flow Immunoassay for Diacetoxyscirpenol
por: Shao, Shibei, et al.
Publicado: (2022)

Electrochemical Enzyme Immunoassay
por: Halsall, H. Brian, et al.
Publicado: (1988)

Immunohistochemical localisation of tissue plasminogen activator in human brain tumours.
por: Franks, A. J., et al.
Publicado: (1989)

Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system
por: van der Knaap, R.H.P., et al.
Publicado: (2015)

Diagnosing Human Fascioliasis Using ELISA Immunoassays at a Tertiary Referral Hospital in Hanoi: A Cross-Sectional Study
por: Nguyen Thu, Huong, et al.
Publicado: (2022)

Comparison of commercial allergen ELISA kits for egg detection in food matrices
por: Smits, Nathalie G.E., et al.
Publicado: (2023)

Immunohistochemistry of local immunoglobulin production in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours()()
por: Knight, James C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qirhu7titvm1il8mfi0pqm8mde